Login to Your Account



Coley IPO, Placement Brings In $106M For TLR Drug Discovery

By Karen Pihl-Carey


Thursday, August 11, 2005
Leading all biotech initial public offerings conducted this year in the U.S., Coley Pharmaceutical Group Inc. topped the list with proceeds of $96 million, then raised another $10 million through a concurrent private placement with Pfizer Inc.(BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription